Choice of Prosthetic Heart Valve in Adults. An Update

Journal of the American College of Cardiology

Volumn 55, Issue 22, 2010, Pages 2413-2426

  Rahimtoola, Shahbudin H ^a  

^a Griffith Center   (United States)

Author keywords

aortic valve replacement; autograft; bioprosthesis; homograft; mechanical heart valve; mitral valve replacement

Indexed keywords

WARFARIN;

ADULT; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; BLEEDING; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; HYDRODYNAMICS; INTERMETHOD COMPARISON; MITRAL VALVE PROSTHESIS; PATIENT SELECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW; SURGICAL MORTALITY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; BIOPROSTHESIS; DISEASE MODELS, ANIMAL; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77952589432     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.085     Document Type: Review

References (109)

1. Operations. In: Strauss M.B. (Ed). Familiar Medical Quotations (1968), Little Brown & Company, Boston, MA 351
2. Rahimtoola S.H. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41 (2003) 893-904
3. Hammermeister K.E., Sethi G.K., Henderson W.C., Grover F.L., Oprian C., and Rahimtoola S.H. Outcomes 15 years after valve replacement with a mechanical versus bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36 (2000) 1152-1158
4. Rahimtoola S.H. Lessons learned about the determinants of the results of valve surgery. Circulation 78 (1988) 1503-1507
5. Brown J.M., O'Brien S.M., Wu C., Sikora J.A.H., Griffith B.P., and Gammie J.S. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 137 (2009) 82-90
6. Edwards F.H., Grover F.L., Shroyer A.L., et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 58 (1994) 1841-1844
7. Alexander K.P., Anstrom K.J., Muhlbaier L.H., et al. Outcomes of cardiac surgery in patients age ≥80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 35 (2000) 731-738
8. Edwards F.H., Petersen E.D., Coombs L.P., et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37 (2001) 885-892
9. Rankin J.S., Hammill B.G., Ferguson Jr. T.B., et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 131 (2006) 547-557
10. Hannan E.L., Wu C., Bennett E.V., et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 83 (2007) 921-930
11. Brown J.R., Cochran R.P., Mackenzie T.A., et al. Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg 86 (2008) 4-12
12. Herzog C.A., Ma J.Z., and Collins A.J. Long-term survival of dialysis patients in the United States with prosthetic heart valves. Should ACC/AHA practice guidelines on valve selection be modified?. Circulation 105 (2002) 1336-1341
13. Toumpoulis I.K., Chamogeorgakis T.P., Angouras D., Swistel D.G., Anagnostopoulas C.E., and Rokkas C.K. Independent predictors for early and long-term mortality after heart valve surgery. J Heart Valv Dis 17 (2008) 548-556
14. Rahimtoola S.H. Valve replacement-a perspective. Am J Cardiol 35 (1975) 711-715
15. Murday A.J., Hochstitzky A., Mansfield J., et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann Thorac Surg 76 (2003) 66-73
16. Bryan A.J., Rogers C.A., Bayliss K., Wild J., and Angelini G.D. Prospective randomized comparison of Carbomedics and St. Jude Medical bileaflet mechanical heart valve prosthesis: ten year follow-up. J Thorac Cardiovasc Surg 133 (2007) 614-622
17. Gao G., Wu Y.X., Grunkemeier G.L., Furnary A.P., and Starr A. Forty-year survival with the Starr-Edwards heart valve prosthesis. J Heart Valve Dis 13 (2004) 91-96
18. Butchart E.G., Li H.H., Payne N., Buchan K., and Grunkemeier G.L. Twenty years experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 121 (2001) 1090-1100
19. Svennebig J.L., Abdelnoor M., and Nitter-Hauge S. Twenty five year experience with Medtronic Hall valve prosthesis in the aortic position. A follow-up cohort study of 816 consecutive patients. Circulation 116 (2007) 1795-1800
20. Kalkat M.S., Edwards M.B., Taylor K.M., and Bonser R.S. Composite aortic valve graft replacement: mortality outcomes in a national registry. Circulation 116 Suppl 1 (2007) 301-306
21. Ali A., Abu-Omar Y., Patel A., et al. Propensity analysis of survival after subcoronary or root replacement techniques for homograft aortic valve replacement. J Thorac Cardiovasc Surg 137 (2009) 334-341
22. Yacoub M., Klieverik L.M., Melina G., et al. An evaluation of the Ross operation in adults. J Heart Valv Dis 15 (2006) 531-539
23. Takkenberg J.J.M., Klieverik L.M.A., Schoof P.H., et al. The Ross procedure: a systematic review and meta-analysis. Circulation 119 (2009) 222-228
24. David T.E. Ross procedure at the crossroads. Circulation 119 (2009) 207-209
25. David T.E., Feindel C.M., Bos J., Ivanou J., and Armstrong S. Aortic valve replacement with Toronto SPV bioprosthesis. J Thorac Cardiovasc Surg 135 (2008) 19-24
26. Grunkemeier G.L., Li H.-H., Naftel D.C., Starr A., and Rahimtoola S.H. Long-term performance of heart valve prosthesis. Curr Probl Cardiol 25 (2000) 73-156
27. Hickey E., Langley S.M., Allemby-Smith, Livesey S.A., and Monro J.L. Subcoronary allograft aortic valve replacement: parametric risk-hazard outcome analysis to a minimum of 20 years. Ann Thorac Surg 84 (2007) 1564-1570
28. Klieverik L.M.A., Bekkers J.A., Roos J.W., et al. Autograft or allograft aortic valve replacement in young adult patients with congenital aortic valve disease. Eur Heart J 29 (2008) 1446-1453
29. Klieverik L.M., Takkenberg J.J., Bekkers J.A., Roos-Hesselink J.W., Witsenberg M., and Borgers A. The Ross operation: a Trojan horse?. Eur Heart J 28 (2007) 1993-2000
30. Luciani G.B., Casali G., Favaro A., et al. Fate of aortic root late after Ross operation. Circulation 108 Suppl 2 (2003) 61-67
31. Matsuki O., Okita Y., Almeida R.S., et al. Two decades experience with aortic valve replacement with pulmonary autograft. J Thorac Cardiovasc Surg 95 (1988) 705-711
32. Ross D., Jackson M., and Davies J. The pulmonary autograft: a permanent aortic valve. Eur J Cardiothorac Surg 6 (1992) 113-117
33. Chambers J.C., Somerville J., Stone S., et al. Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. Circulation 96 (1997) 2206-2214
34. Byrne J.G., Karavas A.N., Mihaljevic T., Rawn J.D., Aranki S.F., and Cohn L.H. Role of cryopreserved homograft in isolated elective aortic valve replacement. Am J Cardiol 91 (2003) 616-619
35. Ross D.N. The pulmonary autograft. Ross principle (or Ross procedural confusion). J Heart Valv Dis 9 (2000) 174-175
36. Nambi V., and Ballantyne C.M. Risky business. Ten years is not a lifetime. Circulation 119 (2009) 362-2
37. Wilhelm M.J., Tavakoli R., Schneeberger K., et al. Cryopreserved aortic viable homograft for active aortic endocarditis. Ann Thorac Surg 79 (2005) 67-71
38. Rahimtoola S.H. The year in valvular heart disease. J Am Coll Cardiol 53 (2009) 1894-1908
39. Oxenham H., Bloomfield P., Wheatly D.J., et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 89 (2003) 715-721
40. Schelbert E.B., Vaughan-Sarrazin M.S., Welke K.F., and Rosenthal G.E. Valve type and long-term outcomes after aortic valve replacement in older patients. Heart 94 (2008) 1181-1188
41. Petersen P., Grind M., Alder J., and SPORTIF II Investigators. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. J Am Coll Cardiol 41 (2003) 1445-1451
42. Kimmell S.E., Chen Z., Price M., et al. The influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med 167 (2007) 229-235
43. Singer D.E., Chang Y., Fang M.C., et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 151 (2009) 297-305
44. Poli D., Antonucci E., Grifoni E., Abbate R., Gensini G.F., and Prisco D. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol 54 (2009) 999-1002
45. Aupart M., Diemont F., Babuty D., Fanchier L., Sivinelli A., and Marchand M. Results intermediares avec la prosteses valvulaire a ailettes carbomedics. Arch Mal Coeur Vaiss 90 (1997) 457-462
46. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 348 (1996) 633-638
47. Florath I., Albert A., Rosendahl U., Alexander T., Ennker I.C., and Ennker J. Mid-term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves. Heart 91 (2005) 1023-1029
48. Hylek E.M., Evans-Molina C., Shea C., Henault L.E., and Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115 (2007) 2689-2696
49. Durrleman N., Pellerin M., Bouchard D., et al. Prosthetic valve replacement: twenty year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg 127 (2004) 1388-1392
50. Cunanan C.M., Cabiling C.M., Shen S., et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 71 Suppl (2001) 417-421
51. Puvimanasinghe J.P.A., Steyerberg E.W., Takkenberg J.J.M., et al. Prognosis after aortic valve replacement with a bioprosthesis. Predictions based on meta-analysis and microsimulation. Circulation 103 (2001) 1535-1541
52. Bonow R.O., Carabello B., and de Leon Jr. A.C. ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 32 (1998) 1486-1588
53. Svensson L.G., Blackstone E.H., and Cosgrove III D. Surgical options in young adults with aortic valve disease. Curr Probl Cardiol 28 (2003) 413-480
54. Takkenberg J.J.M., van Herwerden L.A., Eijkemanas M.J.C., Bekkers J.A., and Bogers A.J.J.C. Evolution of allograft aortic valve replacement over 13 years: results of 275 procedures. Eur J Cardiothorac Surg 21 (2002) 683-691
55. Grunkemeier G.L., and Bodnar E. Comparative assessment of bioprosthesis durability in the aortic position. J Heart Valv Dis 4 (1995) 49-55
56. Lawton J.S., Moazami N., Pasque M.K., Moon M.R., and Damiano Jr. R. Early stenosis of Medtronic Mosaic porcine valve in the aortic position. J Thorac Cardiovasc Surg 137 (2009) 1556-1557
57. Frater R.W.M., Furlong P., Cosgrove P.M., et al. Long-term durability and patient functional status of the Carpentier-Edwards Perimount pericardial bioprosthesis in the aortic position. J Heart Valv Dis 7 (1998) 48-53
58. Porier N.C., Pelletier L.C., Pellerin M., and Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 66 Suppl (1998) 57-61
59. Biglioli P., Spampinato N., Cannata A., et al. Long-term outcomes of the Carpentier-Edwards pericardial valve prosthesis in the aortic position: effect of patient age. J Heart Valv Dis 13 Suppl 1 (2004) 49-51
60. Nakajima H., Aupart M.R., Neville P.H., Sirinelli A.L., Meurisse Y.A., and Marchand M.A. Twelve-year experience with the 19 mm Carpentier-Edwards pericardial aortic valve. J Heart Valv Dis 7 (1998) 534-539
61. Banbury M.K., Cosgrove III D.M., Lytle B.W., Smedira N.G., Sabik J.F., and Saunders C.R. Long-term results of the Carpentier-Edwards pericardial aortic valve: a 12 year follow-up. Ann Thorac Surg 66 Suppl (1998) 73-76
62. Dellgren G., David T.E., Raanani E., Armstrong S., Ivanov J., and Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 124 (2002) 146-154
63. Neville P.H., Aupart M.R., Diemont F.F., Sirinelli A.L., Lemoine E.M., and Marchand M.A. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: A 12 year experience. Ann Thorac Surg 66 (1998) S143-S147
64. Banbury M.K., Cosgrove III D.M., White J.A., Blackstone E.H., Frater R.W.M., and Okies J.E. Age and valve size effect on long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 72 (2001) 753-757
65. Borger M.A., Ivanov J., Armstrong S., Christie-Hrybinsky D., Feindel C.M., and David T.E. Twenty year results of the Hancock II bioprosthesis. J Heart Valv Dis 15 (2006) 49-56
66. Yun K.L., Miller D.C., Moore K.L., et al. Durability of the Hancock MO bioprosthesis compared with the standard aortic valve bioprosthesis. Ann Thorac Surg 60 (1995) 5221-5228
67. Myken P.S.U., and Bech-Hansen O. A 20 year experience of 1712 patients with Bicor porcine bioprosthesis. J Thorac Cardiovasc Surg 137 (2009) 76-81
68. Yankah C.A., Pasic M., Musci M., et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg 136 (2008) 688-696
69. Minami K., Zitterman A., Schulte-Eistrup S., Koertke H., and Korfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 80 (2005) 1699-1705
70. Sjögren J., Gudbjartsson T., and Thulin L.I. Long-term outcome of the Mitroflow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valv Dis 15 (2006) 197-202
71. Alvarez J.R., Sierra J., Vega M., et al. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly. Interact Cardiovasc Thorac Surg 9 (2009) 842-846
72. Houel R., Le Besnerais P., Soustelle C., Kirsch M., Hillion M.D., and Loisance D. Lack of durability of the Mitroflow valve does not affect survival. J Heart Valv Dis 8 (1999) 368-375
73. Kirali A., Guler M., Tuncer A., et al. Fifteen year clinical experience with the Bicor porcine bioprostheses in the mitral position. Ann Thorac Surg 71 (2001) 811-815
74. Marchand M., Aupart M., Norton R., et al. Twelve-year experience with Carpentier-Edwards Perimount pericardial valve in the mitral position: a multicenter study. J Heart Valv Dis 7 (1998) 292-298
75. Jamieson W.R.E., Marchand A., Pelletier C.L., et al. Structural valve deterioration in mitral replacement surgery. Comparison of Carpentier-Edwards supra-annular porcine and Perimount pericardial. J Thorac Cardiovasc Surg 118 (1999) 297-305
76. Birkmeyer N.J.O., Birkmeyer J.D., Tosteson A.N.A., Grunkemeier G.L., Marrin C.A.S., and O'Connor. Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg 70 (2000) 1946-1952
77. van Geldorp M.W.A., Jamieson W.R.E., Kappetein A.P., et al. Patient outcome after aortic valve replacement with mechanical or biological prosthesis. Weighing lifetime anticoagulant related event risk against reoperation risk. J Thorac Cardiovasc Surg 137 (2009) 881-886
78. Starr A., and Grunkemeier G.L. The expected lifetime of porcine valves. Ann Thorac Surg 48 (1989) 317-318
79. Grunkemeier G.L., and Wu Y.X. Actual versus actuarial event-free percentages. Ann Thorac Surg 72 (2001) 677-678
80. Bodnar E., and Blackstone E.H. An "actual" problem: another issue of apples and oranges. J Thorac Cardiovasc Surg 131 (2006) 1-3
81. The Oxford Universal Dictionary (1964), Rand McNally, Chicago, IL 19
82. Websters New Universal Unabridged Dictionary. Deluxe 2nd edition (1983), Simon & Shuster, New York, NY 20
83. Grunkemeier G.L., Takkenberg J.J.M., Jamieson W.R.E., and Miller D.C. Reporting "actual freedom" should not be banned (letter). J Thorac Cardiovasc Surg 132 (2006) 460-461
84. Bodnar E., and Blackstone E.H. Reply to the Editor. J Thorac Cardiovasc Surg 132 (2006) 460
85. Khuri S.F., Folland E.D., Sethi G.K., et al. Six month post-operative hemodynamics of the Hancock heterograft and Bjork-Shiley prosthesis: results of the Veterans Administration cooperative prospective randomized trial. J Am Coll Cardiol 12 (1988) 8-18
86. Pibarot P., and Dumesnil J.G. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic position and its prevention. J Am Coll Cardiol 36 (2000) 1131-1141
87. Rahimtoola S.H. The problem of valve prosthesis-patient mismatch. Circulation 58 (1978) 20-24
88. Rahimtoola S.H. Is severe valve prosthesis-patient mismatch (VP-PM) associated with higher mortality?. Eur J Cardiothorac Surg 30 (2006) 1
89. Bleiziffer S., Eichinger W.B., Hettioh L., et al. Prediction of valve prosthesis-patient mismatch prior to aortic valve replacement: which is the best method?. Heart 93 (2007) 615-620
90. Rahimtoola S.H., and Murphy E. Valve prosthesis-patient mismatch: long-term sequel. Br Heart J 45 (1981) 331-335
91. Magne J., Mathieu P., Dumesnil J.C., et al. Impact of prosthesis-patch mismatch on survival after mitral valve replacement. Circulation 115 (2007) 1417-1425
92. Lam B.-K., Chan V., Hendry P., et al. The impact of prosthesis patient mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg 133 (2007) 1464-1473
93. Marquez S., Hon R.T., and Yoganathan A.P. Comparative hydrodynamic evaluation of bioprosthetic heart valves. J Heart Valv Dis 10 (2001) 802-811
94. Bottio T., Caprilio L., Casarotto D., and Gerosa G. Small aortic annulus: the hemodynamic performances of 5 commercially available bileaflet valves. J Thorac Cardiovasc Surg 128 (2004) 457-462
95. Kuehnel R.-U., Puchner R., Pohl A., et al. Characteristics resistance curves of aortic valve substitutes facilitate individualized decision for a particular patient. Eur J Cardiothorac Surg 27 (2005) 450-455
96. Rahimtoola S.H. The year in valvular heart disease. J Am Coll Cardiol 47 (2006) 427-439
97. Zoghbi W.A., Chambers J.B., Dumesnil J.G., et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Endocardiogr 22 (2009) 975-1014
98. Walther T., Lehmann S., Falk V., et al. Prospective randomized evaluation of stented xenograft. Hemodynamic function in the aortic position. Circulation 110 Suppl 2 (2004) 74-78
99. Botzenhardt F., Eichinger W.B., Bleiziffer S., et al. Hemodynamic comparison of bioprosthesis for complete supra-annular position in patients with small aortic annulus. J Am Coll Cardiol 45 (2005) 2054-2060
100. Cohen G., Christakis G.T., Joyner C.D., et al. Are stentless valves hemodynamically superior to stented valves?. A prospective randomized trial. Ann Thorac Surg 73 (2002) 767-778
101. Chambers J.B., Rimington H.M., Hodson F., Rajani R., and Blauth C.I. The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg 131 (2006) 878-882
102. Totaro P., Degno N., Zaidi A., Youhana A., and Argano V. Carpentier Perimount Magna bioprosthesis: a stented valve with stentless performance?. J Thorac Cardiovasc Surg 130 (2005) 1668-1674
103. Abelenoor M., Nitter H., and Trettli S. Relative survival of patients after heart valve replacement. Eur Heart J 11 (1990) 23-28
104. Lindblom D., Lindblom U., Qvist J., and Lundstrom H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol 15 (1990) 566-573
105. Puvimanasinghe J.P.A., Steyerberg E.W., Takkenberg J.J.M., et al. Prognosis after aortic valve replacement with a bioprosthesis. Predictions based on meta-analysis and microsimulation. Circulation 103 (2001) 1535-1541
106. Hung L., and Rahimtoola S.H. Prosthetic heart valves and pregnancy. Circulation 107 (2003) 1240-1246
107. Trimn J., Hung L., and Rahimtoola S.H. Prosthetic heart valves and pregnancy. In: Oakley C., and Warnes C. (Eds). Heart Disease in Pregnancy (2007), Blackwell Publishers, London 104-121
108. Jamieson W.R.E., Miyagshima R.T., Burr L.H., Lichtenstein S.V., Fradet G.J., and Janusz M.T. Carpentier-Edwards porcine bioprosthesis: clinical performance assessed by actual analysis. J Heart Valv Dis 9 (2000) 530-535
109. Rahimtoola S.H. Valvular heart disease: a century of progress. Am J Med 121 (2008) 664-673